$0.8446
-0.05-5.18%
At close: -
$0.8446
0.000.00%
After Hours: 4:15 PM EDT
Comments
Loading...
Werewolf Therapeutics Analyst Ratings and Price Targets | NASDAQ:HOWL | Benzinga
Werewolf Therapeutics Inc has a consensus price target of $10.38 based on the ratings of 6 analysts. The high is $17 issued by SVB Leerink on May 11, 2022. The low is $4 issued by JMP Securities on January 14, 2025. The 3 most-recent analyst ratings were released by Wedbush, HC Wainwright & Co., and JMP Securities on March 12, 2025, March 12, 2025, and January 14, 2025, respectively. With an average price target of $9 between Wedbush, HC Wainwright & Co., and JMP Securities, there's an implied 965.59% upside for Werewolf Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wedbush
HC Wainwright & Co.
JMP Securities
EF Hutton
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Werewolf Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/12/2025 | Buy Now | 847.19% | Wedbush | Robert Driscoll44% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 03/12/2025 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 01/14/2025 | Buy Now | 373.6% | JMP Securities | Reni Benjamin47% | $12 → $4 | Maintains | Market Outperform | Get Alert |
| 11/19/2024 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 07/02/2024 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2024 | Buy Now | 1320.79% | JMP Securities | Reni Benjamin47% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/26/2024 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | 1320.79% | JMP Securities | Reni Benjamin47% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/03/2024 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/06/2024 | Buy Now | 1320.79% | JMP Securities | Reni Benjamin47% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/06/2024 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | Buy Now | 1320.79% | JMP Securities | Reni Benjamin47% | → $12 | Initiates | → Market Outperform | Get Alert |
| 03/07/2024 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $15 → $15 | Maintains | Buy | Get Alert |
| 11/15/2023 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2023 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2023 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/24/2023 | Buy Now | 965.59% | Wedbush | Robert Driscoll44% | → $9 | Initiates | → Outperform | Get Alert |
| 08/10/2023 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/25/2023 | Buy Now | 882.71% | EF Hutton | Michael King44% | → $8.3 | Assumes | → Buy | Get Alert |
| 05/12/2023 | Buy Now | 1083.99% | B of A Securities | Jason Zemansky72% | $9 → $10 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 03/24/2023 | Buy Now | 882.71% | EF Hutton | Michael King44% | → $8.3 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | Buy Now | 965.59% | B of A Securities | Jason Zemansky72% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 03/23/2023 | Buy Now | 1675.99% | HC Wainwright & Co. | Andres Maldonado43% | $20 → $15 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | Buy Now | 882.71% | EF Hutton | Michael King44% | → $8.3 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | Buy Now | 882.71% | EF Hutton | Michael King44% | → $8.3 | Reiterates | → Buy | Get Alert |
| 01/30/2023 | Buy Now | 847.19% | B of A Securities | Jason Zemansky72% | $9 → $8 | Maintains | Buy | Get Alert |
| 12/05/2022 | Buy Now | 882.71% | EF Hutton | Michael King44% | → $8.3 | Initiates | → Buy | Get Alert |
| 06/02/2022 | Buy Now | 2267.98% | HC Wainwright & Co. | Andres Maldonado43% | → $20 | Assumes | → Buy | Get Alert |
| 05/11/2022 | Buy Now | 1912.79% | SVB Leerink | Daina Graybosch43% | $18 → $17 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Werewolf Therapeutics (HOWL) stock?
The latest price target for Werewolf Therapeutics (NASDAQ:HOWL) was reported by Wedbush on March 12, 2025. The analyst firm set a price target for $8.00 expecting HOWL to rise to within 12 months (a possible 847.19% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?
The latest analyst rating for Werewolf Therapeutics (NASDAQ:HOWL) was provided by Wedbush, and Werewolf Therapeutics reiterated their outperform rating.
When was the last upgrade for Werewolf Therapeutics (HOWL)?
There is no last upgrade for Werewolf Therapeutics
When was the last downgrade for Werewolf Therapeutics (HOWL)?
There is no last downgrade for Werewolf Therapeutics.
When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on March 12, 2025 so you should expect the next rating to be made available sometime around March 12, 2026.
Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?
While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $8.00 to $8.00. The current price Werewolf Therapeutics (HOWL) is trading at is $0.84, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
